Disease-Specific Markers for the Mucopolysaccharidoses

Pediatric Research - United States
doi 10.1203/01.pdr.0000141987.69757.dd
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Glycan-Based Biomarkers for the Mucopolysaccharidoses

Molecular Genetics and Metabolism
GeneticsMolecular BiologyBiochemistryEndocrinologyMetabolismDiabetes
2011English

Emerging Treatment Options for the Mucopolysaccharidoses

Research and Reports in Endocrine Disorders
2012English

Surrogate Markers for Cardiovascular Disease: Structural Markers

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Innovative Treatments for Mucopolysaccharidoses

Journal of Child Science
Child HealthSurgeryPediatricsPerinatology
2018English

Disease Specific Characteristics of Fetal Epigenetic Markers for Non-Invasive Prenatal Testing of Trisomy 21

BMC Medical Genomics
Genetics
2014English

Advances in the Development of Pharmacological Chaperones for the Mucopolysaccharidoses

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Cathepsins in the Pathophysiology of Mucopolysaccharidoses: New Perspectives for Therapy

Cells
2020English

Outcome of Penetrating Keratoplasty for Mucopolysaccharidoses

Archives of Ophthalmology
2011English

Replacement Therapy in the Mucopolysaccharidoses

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1978English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy